Clinical Trials in Boston

Showing 11541-11560 of 17,836 trials

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

NCT03145025

An Observational Change-From-Baseline Evaluation of Corneal Endothelial Cell Density in Eyes Treated with a Fluocinolone Acetonide Intravitreal Implant

Uveitis, Posterior

Bausch & Lomb Incorporated3 participantsStarted Jul 2017

Boston, Massachusetts, United States

COMPLETED< 1 mile

Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

NCT01060787

Investigate the impact of the Fluocinolone Acetonide (FA) intravitreal implants

InflammationUveitis

Bausch & Lomb Incorporated98 participantsStarted Feb 2016

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches

NCT01740219

This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.

Cancer

Dana-Farber Cancer Institute348 participantsStarted Sep 2011

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Medford, Massachusetts, United States

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches

Find Trials by Condition in Boston

Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PAD

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

ALternate Site Cardiac ReSYNChronization (ALSYNC) Study

A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta